Skip to main content
. 2022 Dec 25;10(6):2204932. doi: 10.1002/advs.202204932

Figure 15.

Figure 15

a) Scheme of antitumor immunity induced by LZnP‐NP‐based peptide vaccines. Reproduced with permission.[ 205 ] Copyright 2015, Elsevier. b) Schematic illustration of TLS‐loaded LZnP nanovaccine combined with immune checkpoint antagonist dPPA‐1 to induce antitumor immunity. Reproduced with permission.[ 206 ] Copyright 2018, Wiley‐VCH. c) Construction of pC9sTgf@MLNs and proposed mechanisms for its restructuring of the tumor immune microenvironment. Reproduced with permission.[ 207 ] Copyright 2021, American Chemical Society.